This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Oventus Medical Past Earnings Performance

Past criteria checks 0/6

Key information

-14.3%

Earnings growth rate

6.1%

EPS growth rate

Medical Equipment Industry Growth5.8%
Revenue growth rate23.3%
Return on equity-128.9%
Net Margin-941.3%
Last Earnings Update31 Dec 2021

Recent past performance updates

Recent updates

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Oventus Medical Limited's (ASX:OVN) CEO For Now

Nov 11
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Oventus Medical Limited's (ASX:OVN) CEO For Now

Is Oventus Medical (ASX:OVN) In A Good Position To Invest In Growth?

May 09
Is Oventus Medical (ASX:OVN) In A Good Position To Invest In Growth?

Is Oventus Medical (ASX:OVN) In A Good Position To Invest In Growth?

Jan 24
Is Oventus Medical (ASX:OVN) In A Good Position To Invest In Growth?

Loss-Making Oventus Medical Limited (ASX:OVN) Expected To Breakeven In The Medium-Term

Nov 30
Loss-Making Oventus Medical Limited (ASX:OVN) Expected To Breakeven In The Medium-Term

Revenue & Expenses Breakdown
Beta

How Oventus Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ASX:OVN Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 211-10100
30 Sep 211-1090
30 Jun 211-1090
31 Mar 211-1090
31 Dec 201-1081
30 Sep 201-1091
30 Jun 200-1091
31 Mar 200-1090
31 Dec 190-980
30 Sep 190-980
30 Jun 190-870
31 Mar 190-770
31 Dec 180-760
30 Sep 180-660
30 Jun 180-650
31 Mar 180-660
31 Dec 170-660
30 Sep 170-660
30 Jun 170-760
31 Mar 171-650
31 Dec 161-540
30 Sep 161-430
30 Jun 161-220

Quality Earnings: OVN is currently unprofitable.

Growing Profit Margin: OVN is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: OVN is unprofitable, and losses have increased over the past 5 years at a rate of 14.3% per year.

Accelerating Growth: Unable to compare OVN's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: OVN is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-25.3%).


Return on Equity

High ROE: OVN has a negative Return on Equity (-128.86%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.